ArticlePolymers2021
The Effect of Poly (Ethylene glycol) Emulation on the Degradation of PLA/Starch Composites.
Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 45 citations in OpenAlex.
- Pulmonary toxicity of micro- and nano polyethylene particles following intratracheal instillation in rats.Particle and fibre toxicology · 2026Article
- 3D-Printed PLDLA-TMC/PEG 400 Vascular Scaffolds with a Poly(hexamethylene Biguanide) Antibacterial Coating.Pharmaceutics · 2026Article
- Article
- Hydrophilic Components as Key Active Ingredients in Adipose-Derived Matrix Bioscaffolds for Inducing Fat Regeneration.Advanced healthcare materials · 2024Article
- Article
- The Mechanical Properties and Degradation Behavior of 3D-Printed Cellulose Nanofiber/Polylactic Acid Composites.Materials (Basel, Switzerland) · 2023Article
- Article
- Curing Kinetics Modeling of Epoxy Modified by Fully Vulcanized Elastomer Nanoparticles Using Rheometry Method.Molecules (Basel, Switzerland) · 2022Article
- Review
- The Life Cycle Assessment for Polylactic Acid (PLA) to Make It a Low-Carbon Material.Polymers · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a hydrophilic renewable polymer, starch has been widely used in biocompatible plastics as a filler for more than two decades. The present study aimed at investigating the effects of polyethylene glycol (PEG), as a plasticizer, on the physicochemical properties of a hybrid composite-polylactic acid (PLA) and thermoplastic starch (TPS). A solvent evaporation process was adopted to gelatinize the starch and disparate PEG contents ranging from 3 to 15 wt.% (with respect to the sample weight) were examined. It was revealed that the increase in the PEG content was accompanied by an increment in the starch gelatinization degree. Referring to the microstructural analyses, the TPS/PLA mixture yielded a ductile hybrid composite with a fine morphology and a uniform phase. Nevertheless, two different solvents, including acetone and ethanol, were used to assess if they had any effect on the hybrid's morphology, tensile strength and thermal properties. It was found that ethanol culminated in a porous hybrid composite with a finer morphology and better starch distribution in the PLA structure than acetone. As the result of PEG addition to the composite, the crystallinity and tensile strength were decreased, whereas the elongation increased. The hydrolytic degradation of samples was assessed under different pH and thermal conditions. Moreover, the microbial degradation of the PLA/TPS hybrid composite containing different PEG molar fractions was investigated in the soil for 45 days. The rate of degradation in both hydrolytic and biodegradation increased in the samples with a higher amount of PEG with ethanol solvent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.